Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
UX-GIP001
- Development stage
- Phase 1
- Lead developer
- UniXell Biotechnology
- Modality
- Cell Therapies
- Administration
- Intracerebral
01
Overview
UX-GIP001 is an investigational cell therapy product consisting of human GABAergic interneuron progenitor (GIP) cells. Developed by Uni-X Bioscience, it is intended to treat adult patients with drug-resistant unilateral mesial temporal lobe epilepsy (MTLE). The therapy utilizes a regenerative approach where progenitor cells are delivered via stereotactic neurosurgery directly into the epileptic focus. Once integrated, these cells are designed to differentiate into mature GABAergic interneurons that release gamma-aminobutyric acid (GABA), the primary inhibitory neurotransmitter in the central nervous system. By restoring the balance between excitatory and inhibitory signaling, UX-GIP001 aims to reduce seizure frequency and address the underlying pathophysiology of MTLE in patients who do not respond to conventional anti-epileptic medications.
- Other names
- Human GABAergic interneuron progenitor cellsUX-GIP001 InjectionUX-GIP-001 InjectionUX-GIP 001 InjectionGIP cell therapy
Beyond the preview
Go deeper on UX-GIP001.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on UX-GIP001.